We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Biosensing Platform Combined with Machine Learning to Enable Minimally-Invasive Detection of Alzheimer's

By LabMedica International staff writers
Posted on 28 Oct 2022
Print article
Image: Researchers are exploring the use of ML for a minimally invasive system to detect Alzheimer\'s disease (Photo courtesy of NIH)
Image: Researchers are exploring the use of ML for a minimally invasive system to detect Alzheimer\'s disease (Photo courtesy of NIH)

Alzheimer's disease is a severe neurodegenerative disorder characterized by progressive memory, cognitive impairment and personality changes, which can further evolve to dementia and death. Early detection allows doctors to give timely treatments and interventions for the patient. Currently, doctors rely on several biomarkers - substances in an organism that can indicate the existence of a disease or condition - to detect Alzheimer's disease. However, collecting data that inform about these biomarkers is expensive and can be time-consuming. Now, a machine learning system being developed could provide a minimally invasive approach for detecting Alzheimer's disease as early as possible.

A team of researchers led by Penn State (University Park, PA, USA) has received a USD 1.2 million grant from the National Institutes of Health (NIH, Bethesda, MD, USA) to help fund a project to develop a machine learning system for early Alzheimer’s disease detection. The research team plans to design a system that utilizes a variety of biosensors, including optical, mechanical and electrochemical nano-sensors, that can analyze biological samples. According to the researchers, biosensing data matches well with the capabilities of machine learning techniques and the combination of the two technologies could even pave the way to new discoveries for other conditions and disease. Currently, the team is analyzing animal biological samples, but, if these initial inquiries prove successful, the researchers will move on to study human biological samples.

“By integrating a multimodal biosensing platform and a machine learning framework, we expect the system to improve early detection of Alzheimer's disease and enhance AD detection accuracy,” said Fenglong Ma, assistant professor of information sciences and technology and Institute for Computational and Data Sciences co-hire. “The biosensing platform will generate different types of sensing data, and machine learning aims to analyze these data to predict Alzheimer’s in the early stage. Since the sensing data are so diverse - or heterogeneous - advanced machine learning techniques can help model such data. Also, machine learning may help us identify some new AD biomarkers.”

“Given different types of sensing data, for instance, data acquired from different biochemical markers in human body fluids, machine learning can perform feature selection and establish associations between an individual biomarker and Alzheimer's disease, or between a set of biomarkers and the disease,” said Sharon Huang, professor of information sciences and technology and Huck Institutes of the Life Sciences co-hire. “We hope our project can result in a minimally-invasive technique that can detect Alzheimer's disease in its early stages. The technique also has the potential to be high throughput, making it possible to be used in screening for the disease. We will also try our best to make the technique accurate, reducing false positives and false negatives in AD detection.”

Related Links:
Penn State

Gold Supplier
Blood Glucose Reference Analyzer
Nova Primary
Fecal Occult Blood Test
Fecal Occult Blood (iFOB) Neo
DiaCarta Luminometer
C-Reactive Protein Test
PLUS CRP Turbilatex

Print article


Clinical Chem.

view channel
Image: Equivalence of Genetically Elevated LDL and Lipoprotein(a) on Myocardial Infarction (Photo courtesy of Viborg Regional Hospital)

Familial Hypercholesterolemia Patients With ACD Have Elevated Lipoprotein(a)

Familial hypercholesterolemia (FH) is a genetic disorder characterized by high cholesterol levels, specifically very high levels of low-density lipoprotein (LDL cholesterol), in the blood and early cardiovascular... Read more

Molecular Diagnostics

view channel
Image: A cheap blood test could improve diagnosis of myocarditis (Photo courtesy of Queen Mary University of London)

First-Ever Blood Test Could Detect Deadly Heart Inflammation Within Hours

Myocarditis, or inflammation of the heart muscle, is a difficult condition to diagnose. Symptoms include a temperature, fatigue, chest pain and shortness of breath, which can all be easily mistaken for... Read more


view channel
Image: Ring-form trophozoites of Plasmodium vivax in a thin blood smear (Photo courtesy of Centers for Disease Control and Prevention)

Immune Regulators Predict Severity of Plasmodium vivax Malaria

Cytokines and chemokines are immune response molecules that display diverse functions, such as inflammation and immune regulation. In Plasmodium vivax infections, the uncontrolled production of these molecules... Read more


view channel
Image: Breast cancer spread uncovered by new molecular microscopy (Photo courtesy of Wellcome Sanger Institute)

New Molecular Microscopy Tool Uncovers Breast Cancer Spread

Breast cancer commonly starts when cells start to grow uncontrollably, often due to mutations in the cells. Overtime the tumor becomes a patchwork of cells, called cancer clones, each with different mutations.... Read more


view channel
Image: With Cell IDx’s acquisition, Leica Biosystems will be moving its multiplexing menu forward (Photo courtesy of Leica Biosystems)

Leica Biosystems Acquires Cell IDx, Expanding Offerings in Multiplexed Tissue Profiling

Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging (Nussloch, Germany), has acquired Cell IDx, Inc. (San Diego, CA, USA), which provides multiplex staining... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.